Research snapshot

Laminin-augmented extracellular matrix improves human brain reconstruction

Backstory

Brain organoids are valuable for modeling human brain development and disease but often lack the complex extracellular matrix (ECM) cues needed for proper cell differentiation and balanced inflammatory signaling. While decellularized porcine brain ECM (P-BdECM) provides a biologically relevant scaffold, the decellularization process depletes some of its native ECM proteins, leading to incomplete support for neuronal and glial maturation.

A team of researchers in South Korea (Bae et al., 2024) set out to develop LN111-augmented P-BdECM, designed to compensate for the low tissue-specificity of non-neuronal matrix and to restore components lost during decellularization. Their goal was to construct a more human-like cerebral microenvironment that could better support neural differentiation and immune regulation in brain organoid models.

How laminins helped

Supplementing P-BdECM with LN111 provided essential adhesion and survival cues, working synergistically with LN521 to drive greater neural maturation than compared to other matrices (e.g., Matrigel). Laminin-augmented ECM reduced aberrant baseline neuroinflammation while preserving the ability of glial cells to mount appropriate inflammatory responses when challenged.

Both P- and human-BdECM are rich in LN521, a laminin subtype that supports neural cell stabilization and synapse formation. In the study, LN521 supplementation enhanced neuronal function, as evidenced by increased calcium signal intensity and elevated levels of Tuj1 and Aldh1l1.

Why it matters

  • Authentic brain organoid models. Laminin-111 and laminin-521 restore the missing ECM cues and tissue specificity in P-BdECM, enhancing neural cell adhesion, survival, and differentiation, while promoting neural maturation and function—factors that are crucial for achieving high-fidelity brain organoids for modeling development and disease.
  • Better neuroinflammation research. By modulating glial activity, laminin-augmented ECM enables realistic neuroinflammatory responses, critical for studying conditions such as Alzheimer’s and Parkinson’s, and for developing drugs targeting neuroinflammatory disorders.
  • Translational and clinical potential. As a defined, pathogen-controlled alternative to Matrigel, laminin-supplemented ECM supports GMP-compliant organoid production and opens opportunities for pharma, biotech, and regenerative medicine to create accurate neural screening platforms and personalized therapies.

Cited study: Bae et al., (2024). Laminin-Augmented Decellularized Extracellular Matrix Ameliorating Neural Differentiation and Neuroinflammation in Human Mini-Brains. Small.

Biolaminin ® substrates used in this study:

  • Biolaminin 521 LN (LN521)

    Full-length human recombinant laminin-521

    Biolaminin 521 LN is a full-length laminin-521 substrate—the natural laminin for pluripotent stem cells, reliably facilitating ESC and iPSC self-r […]
    View product

  • Biolaminin 111 LN (LN111)

    Full-length human recombinant laminin-111

    Biolaminin 111 is a full-length laminin-111 protein—an essential extracellular matrix component for many cell types in vivo. It has proven particu […]
    View product